Clinical Trials Directory

Trials / Completed

CompletedNCT02635321

MRI and Muscle Involvement in Patients With Mutations in GMPPB

Status
Completed
Phase
Study type
Observational
Enrollment
4 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Limb girdle muscular dystrophies (LGMD) are a very heterogeneous group of muscle disorders characterized by muscle weakness and atrophy of the proximal muscles of the shoulder and pelvic girdles. LGMD is classified based on its inheritance pattern and genetic cause into more than 31 different types. A new type - type 2T has been found. The genetic cause of type 2T is mutations in Guanosine Diphosphate (GDP)-mannose pyrophosphorylase B (GMPPB). Mutations in GMPPB can also cause Congenital muscular dystrophies (CMD). Only 41 patients with mutations in GMPPB has been reported. In this study, the investigators examine five new cases with the LGMD phenotype. The primary aim is to examine the muscle involvement using MRI.

Conditions

Timeline

Start date
2015-11-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2015-12-18
Last updated
2016-04-06

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02635321. Inclusion in this directory is not an endorsement.